IMPROVE DKD

 

Digital multi-component intervention to IMPROVE the care of older people living with Diabetes and Chronic Kidney Disease - A type 2 hybrid effectiveness-implementation cluster randomised trial

 improve

Design

Type II hybrid effectiveness-implementation cluster randomised trial. The trial includes a study within a trial (SWAT) to assess the value of modelling trial outcomes using process of care data only, compared with intermediate outcome data and later clinical outcomes.

Aim of the Study

The aim of the research is to improve the health and clinical outcomes of people with DKD, through reducing the risk of kidney failure and CV events, and thereby potentially saving cost to the NHS. 

Setting

Primary Care General Practices (GP) across England

Target Population

Healthcare professionals (HCPs) managing the clinical care of patients with type 2 diabetes (T2D).

Intervention

Multicomponent intervention based on the Joint ABCD-UKKA Guidelines recommendations.

The below video explains what the IMPROVE DKD intervention consists of: 

Measurement of outcomes


      • Effectiveness outcome: Change in eGFR over a period of 2 years obtained via routine data collection.
      • Implementation outcome: GP adherence to the five key ABCD-UKKA guideline recommendations: optimising blood pressure (BP) and glycaemic control, and the use of optimum doses of RAASi, SGLT-2i and statin. This will be determined via routine data collection at 12 months post randomisation.